Tranche 2 Warrant Authorization
Company: Core Scientific
The claim, verbatim
Company authorized issuance of 81,984,644 Tranche 2 Warrants, each exercisable for one share of common stock at $0.01 per share conditional on volume-weighted average price reaching $8.72 for 20 consecutive trading days, expiring January 23, 2029.
Source (primary)
Core Scientific SC 13D/A filed 2024-02-20 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the " Tranche 2 Warrants "). Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the " TEV Triggering Event "). The Tranche 2 Warrants expire on January 23, 2029”
How we checked this
Checked on September 18, 2026. The cited source supports every part of this claim.
The filing states the Tranche 2 authorization amount, the $0.01 exercise price, the $8.72 20-day VWAP trigger and the January 23, 2029 expiry.
Confirmed in the source:
- Under the Warrant Agreement, Core Scientific was authorized to issue 81,984,644 Tranche 2 Warrants
- Each Tranche 2 Warrant is exercisable for one share of new common stock at $0.01 per share
- Tranche 2 Warrants become exercisable only after the volume-weighted average price equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days
- The Tranche 2 Warrants expire on January 23, 2029
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312524040115/d784237dsc13da.htm) in full (14,080 characters, retrieved August 31, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific SC 13D/A filed 2024-02-20
Quote: “an aggregate of 81,984,644 warrants, each exercisable for one share of New Common Stock (the " Tranche 2 Warrants "). Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of New Common Stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of New Common Stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the " TEV Triggering Event "). The Tranche 2 Warrants expire on January 23, 2029”